Skip to main content
SpringerLink
Log in

L’orbitopatia basedowiana lieve/moderata: che cosa fare e che cosa non fare

  • Pratica Clinica in Endocrinologia
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Bartalena L, Chiovato L, Vitti P (2016) Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any). J Endocrinol Invest 39(10):1105–1114

    Article  CAS  PubMed  Google Scholar 

  2. Anagnostis P, Boboridis K, Adamidou F, Kita M (2017) Natural course of mild Graves’ orbitopathy: is it a chronic remitting or a transient disease? J Endocrinol Invest 40(3):257–261

    Article  CAS  PubMed  Google Scholar 

  3. Bartalena L, Veronesi G, Krassas GE et al. (2017) Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? J Endocrinol Invest 40(5):547–553

    Article  CAS  PubMed  Google Scholar 

  4. Bartalena L, Baldeschi L, Boboridis K et al. (2016) The 2016 European Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lai A, Sassi L, Compri E et al. (2010) Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves’ orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab 95(3):1333–1337

    Article  CAS  PubMed  Google Scholar 

  6. Marcocci C, Kahaly GJ, Krassas GE et al. (2011) Selenium and the course of mild Graves’ orbitopathy. N Engl J Med 364(20):1920–1931

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina e Chirurgia, Università dell’Insubria, S.C. Endocrinologia, ASST dei Sette Laghi, Ospedale di Circolo, Varese, Italia

    Eliana Piantanida & Luigi Bartalena

Authors
  1. Eliana Piantanida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luigi Bartalena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eliana Piantanida.

Ethics declarations

Conflitto di interesse

Gli autori Eliana Piantanida e Luigi Bartalena dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo studio non hanno eseguito studi sugli animali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piantanida, E., Bartalena, L. L’orbitopatia basedowiana lieve/moderata: che cosa fare e che cosa non fare. L'Endocrinologo 19, 97–98 (2018). https://doi.org/10.1007/s40619-018-0415-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-018-0415-6

Search

Navigation